article thumbnail

Stacey Donnelly

Broad Institute

In 2001, Donnelly joined the Whitehead Institute/MIT Center for Genome Research, now part of the Broad Institute, where she was in charge of the center’s sponsored research portfolio and helped establish and maintain the first high-throughput Specialized Service Facilities (SSFs). Donnelly received her B.A.

article thumbnail

How Targeted Cancer Drugs Disrupt the Cell Cycle

PLOS: DNA Science

After passing safety tests, Gleevec worked so well that it set a new record for drug approval—10 weeks, on May 10, 2001. I had the privilege to meet one of the first people to receive Gleevec, which I wrote about for Bioethics Today in 2006. Like Erin, they had CML.

Drugs 52